Annual report pursuant to Section 13 and 15(d)

REVENUES (Tables)

v3.22.4
REVENUES (Tables)
12 Months Ended
Dec. 31, 2022
REVENUES  
Schedule of revenues disaggregated by category

Revenues disaggregated by category were as follows (in thousands):

Year Ended December 31,

2022

    

2021

    

2020

Product sales:

Gross product sales

$

108,523

$

81,186

$

76,470

Discounts and allowances

(31,805)

 

(18,176)

 

(14,774)

Total product sales, net

76,718

63,010

61,696

Revenues from collaborations:

License revenues

7,932

70,553

40,358

Development milestones

25,000

 

1,875

 

2,100

Research and development services and others

6,092

 

3,298

 

4,467

Total revenues from collaborations

39,024

75,726

46,925

Government contract

4,500

10,500

Total revenues

$

120,242

$

149,236

$

108,621

Schedule of product revenue allowance and reserve categories

Chargebacks,

Government

Discounts and

and Other

Fees

Rebates

Returns

Total

Balance as of January 1, 2022

    

$

3,404

$

2,494

$

2,017

$

7,915

Provision related to current period sales

23,488

5,901

1,514

30,903

Credit or payments made during the period

(20,679)

(5,759)

(235)

(26,673)

Balance as of December 31, 2022

 

$

6,213

$

2,636

$

3,296

$

12,145

Chargebacks,

Government

Discounts and

and Other

Fees

Rebates

Returns

Total

Balance as of January 1, 2021

    

$

2,461

 

$

2,115

$

1,489

$

6,065

Provision related to current period sales

10,731

5,036

1,021

16,788

Credit or payments made during the period

(9,788)

(4,657)

(493)

(14,938)

Balance as of December 31, 2021

 

$

3,404

$

2,494

$

2,017

$

7,915

Schedule of revenues from product sales disaggregated by customers

The following table summarizes revenues from each of our customers who individually accounted for 10% or more (wherein * denotes less than 10%) of the total net product sales and revenues from collaborations:

Year Ended December 31,

2022

    

2021

2020

McKesson Specialty Care Distribution Corporation

31%

20%

23%

Kissei

24%

*

Cardinal Healthcare

19%

*

*

ASD Healthcare and Oncology Supply

17%

17%

30%

Lilly

*

48%

Grifols

*

*

41%